Clinical Trial Update: DZX Mediated Insulin Suppression in Obese Men [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating DZX-mediated insulin suppression in obese men has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• DZX

Snippet

Sponsor: Rijnstate Hospital | Conditions: Obesity | Phase 2 | Status: COMPLETED